BTIG sees Moonlake stock as a buy, driven by sonelokimab’s market growth prospects

Tomas Kauer - Moderator

Sep 12, 2024 - 19:00

0

BTIG sees Moonlake stock as a buy, driven by sonelokimab’s market growth prospects

Tags:

Previous Article

General Mills in talks to sell North America yogurt operations to Lactalis, Sodi...

CyberArk stock gains momentum with rising demand for non&PAM solutions – DA Davi...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator www.tomaskauer.com

Related Posts

Google’s NotebookLM enhances AI note&taking with YouTube, audio file sources, sharable audio discussions

Google’s NotebookLM enhances AI note&taking with YouTub...

Tomas Kauer - Mode... Sep 27, 2024 0

SS&C GlobeOp Hedge Fund Performance Index and Capital Movement Index

SS&C GlobeOp Hedge Fund Performance Index and Capit...

Tomas Kauer - Mode... Sep 14, 2024 0

Cohere co&founder Nick Frosst’s indie band, Good Kid, is almost as successful as his AI company

Cohere co&founder Nick Frosst’s indie band, Good Kid, i...

Tomas Kauer - Mode... Sep 15, 2024 0